Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 16, 2003, Pages 2765-2768

  Casini, Angela ^a   Caccia, Silvio ^b   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; CARBONIC ACID ACTIVATOR; CITALOPRAM; ENZYME ACTIVATOR; FLUOXETINE; ISOENZYME; ISOZYME 1; ISOZYME 2; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVATION; MAJOR DEPRESSION; X RAY ANALYSIS;

EID: 0037811290     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00507-9     Document Type: Article

References (35)

1. Supuran, C. T.; Scozzafava, A. Activation of carbonic anhydrase isozymes. In The Carbonic Anhydrases- New Horizons, Chegwidden, W. R.; Carter, N.; Edwards, Y. Eds.; Birkhauser Verlag: Basel, Switzerland, 2000, p 197.
2. Briganti F., Mangani S., Orioli P., Scozzafava A., Vernaglione G., Supuran C.T. Biochemistry. 36:1997;10384.
3. (a) Briganti F., Iaconi V., Mangani S., Orioli P., Scozzafava A., Vernaglione G., Supuran C.T. Inorg. Chim. Acta. 275-276:1998;295
4. (b) Clare B.W., Supuran C.T. J. Pharm. Sci. 83:1994;768.
5. (a) Supuran C.T., Scozzafava A. Curr. Med. Chem. Imm., Endoc., Metab. Agents. 1:2001;61
6. (b) Supuran C.T., Scozzafava A., Casini A. Med. Res. Rev. 23:2003;146.
7. Carbonic Anhydrase, Its Inhibitors and Activators, Supuran, C. T., Scozzafava, A.; Conway, J. Eds. Taylor & Francis, London & New York, 2003.
8. (a) Sun M.K., Alkon D.L. J. Pharm. Exp. Ther. 297:2001;961
9. (b) Sun M.K., Alkon D.L. Trends Pharmacol. Sci. 23:2002;83.
10. (a) Ghandour M.S., Parkkila A.K., Parkkila S., Waheed A., Sly W.S. J. Neurochem. 75:2000;2212
11. (b) Parkkila S., Parkkila A.K., Rajanemi H., Shah G.N., Waheed A., Sly W.S. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1918
12. (c) Leniger T., Wiemann M., Bingmann D., Widman G., Hufnagel A., Bonnet U. Epilepsia. 43:2002;469.
13. Wiebe S.P., Saubli U.V. J. Neurosci. 21:2001;3955.
14. Meier-Ruge W., Iwanoff P., Reichlmeier K. Arch. Gerontol. Geriatr. 3:1984;161.
15. Geldmacher D.S., Whitehouse P.J. Neurology. 48:1997;S2.
16. Akhondzadeh S., Noroozian M. Investig. Drugs. 5:2002;1062.
17. (a) Caccia S. Clin. Pharmacokinet. 34:1998;281
18. (b) Caccia S. Clin. Pharmacokinet. 38:2000;393.
19. (a) Taragano F.E., Lyketsos C.G., Mangone C.A., Allegri R.F., Comesana-Diaz E. Psychosomatics. 38:1997;246
20. (b) Lyketsos C.G., Sheppard J.M., Steele C.D., Kopunek S., Steinberg M., Baker A.S., Brandt J., Rabins P.V. Am. J. Psychiatry. 157:2000;1686.
21. (a) Briganti F., Scozzafava A., Supuran C.T. Bioorg. Med. Chem. Lett. 9:1999;2043
22. (b) Supuran C.T., Scozzafava A. Bioorg. Med. Chem. 7:1999;2915.
23. (a) Scozzafava A., Supuran C.T. Eur. J. Pharm. Sci. 10:2000;29
24. (b) Scozzafava A., Iorga B., Supuran C.T. J. Enzyme Inhib. 15:2000;139.
25. (a) Scozzafava A., Supuran C.T. Eur. J. Med. Chem. 35:2000;31
26. (b) Supuran C.T., Scozzafava A. J. Enzyme Inhib. 15:2000;471
27. (c) Scozzafava A., Supuran C.T. J. Med. Chem. 45:2002;284
28. (d) Ilies M., Banciu M.D., Ilies M.A., Scozzafava A., Caproiu M.T., Supuran C.T. J. Med. Chem. 45:2002;504.
29. (a) Supuran C.T., Balaban A.T., Cabildo P., Claramunt R.M., Lavandera J.L., Elguero J. Biol. Pharm. Bull. 16:1993;1236
30. (b) Supuran C.T., Claramunt R.M., Lavandera J.L., Elguero J. Biol. Pharm. Bull. 19:1996;1417.
31. Scozzafava A., Supuran C.T. Bioorg. Med. Chem. Lett. 12:2002;1177.
32. 2 solutions in water at 20 °C were used as substrate. Stock solutions of activators were prepared at a concentration of 1-3 mM (in DMSO-water 1:1, v/v) and dilutions up to 10 nM done with the assay buffer mentioned above.
33. 16.
34. Baumann P. Clin. Pharmacokin. 31:1996;444.
35. Caccia S., Anelli M., Codegoni A.M., Fracasso C., Garattini S. Br. J. Pharmacol. 110:1993;355.